Global Health Share Price Ended Lower to ₹1,357.00 In Friday's Session — Volumes, 52-Week Range and What to Watch Next
Quick answer
Global Health (MEDANTA) last traded at ₹1,357.00, -8.00 (-0.59%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Quick summary
Last price
₹1,357.00
-0.59%
Day range
₹1,336.20 – ₹1,386.10
52-week high
₹1,544
Global Health: what is happening in Friday's session
Global Health (MEDANTA) last traded at ₹1,357.00, -8.00 (-0.59%) against a previous close of ₹1,365.00, read from the NSE board at the close of the last trading session on Friday, 2 October 2026. On the tape the move is inside the stock's usual daily range, so the tape is treating the story as information rather than as a reason to reprice.
Indian equity markets are shut on Saturday, so every level below is from the last trading session on Friday, 2 October 2026 and will not change until the next session opens.
Key takeaways
- Where it trades: Global Health is at ₹1,357.00, -8.00 (-0.59%) versus the previous close of ₹1,365.00.
- Why it is moving: an in-focus story — one business desk filed on the company in the last few hours.
- Today's band: ₹1,336.20 to ₹1,386.10, against an open of ₹1,356.90 — the stock is defending its opening print.
- Twelve-month context: 12.11% below the ₹1,544 high and 41.95% above the ₹956 low, so the stock sits in the middle part of its own range.
- Participation: turnover is running at 1.4x the twenty-day average, which is ordinary flow — the move lacks a volume endorsement so far.
- What to watch: an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two.
Why Global Health is on the desks in Friday's session
Global Health is one of the most-mentioned names on the business wires right now — reported by one desk so far, with the headlines linked below. When several desks run the same company on the same day, the flow that follows is usually driven by attention rather than by a single disclosure, so the price move needs volume behind it to mean anything.
Today's quote in numbers
| Field | Value |
|---|---|
| Last price | ₹1,357.00 |
| Change | -8.00 (-0.59%) |
| Open | ₹1,356.90 |
| Day range | ₹1,336.20 – ₹1,386.10 |
| Previous close | ₹1,365.00 |
| Volume | 3,63,086 |
| 52-week range | ₹956 – ₹1,544 |
| 20-day average volume | 2,58,970 |
What it means when several desks run the same name
A publisher filed on Global Health in the last few hours without a single dominant disclosure driving it. Clustered coverage of this kind is usually attention rather than information: a screen result, a sector read-across, or a follow-up to something filed earlier in the week. Attention brings order flow, but order flow without a disclosure behind it decays.
The way to separate the two is participation. A move on turnover at or above the stock's own recent average means positions are changing hands and the level is likely to hold. The same move on thin volume is a handful of trades and reverses easily, which is why the volume column deserves as much attention as the percentage change.
Global Health is at ₹1,357.00, -8.00 (-0.59%), between ₹1,336.20 and ₹1,386.10 on the day, on 1.4x its twenty-day average volume.
Coverage across the desks
Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.
What the tape is saying
Global Health has traded between ₹1,336.20 and ₹1,386.10 in this session against an open of ₹1,356.90 and a previous close of ₹1,365.00. That is a band of ₹49.90, or 3.68% of the current price — an ordinary day's spread, so the move is orderly rather than disorderly.
Holding above the open at ₹1,356.90 matters because it is the level intraday desks use as the session pivot: buyers who entered at the open are in profit, so there is no forced supply from that cohort.
In market-structure terms this is a continuation session, so the prior trend remains the base case until a level breaks.
Performance across horizons
| Period | Return |
|---|---|
| 1W | -9.30% |
| 1M | -8.29% |
| 3M | +0.87% |
| 6M | +37.72% |
| 1Y | +2.12% |
What the returns table is saying
Over the last week Global Health has slipped -9.30% and over the month -8.29%. Both horizons pointing the same way means the recent move is an extension of the existing trend rather than a reversal.
The twelve-month return of +2.12% is the context long-term holders judge the stock on. A moderate one-year move means the stock has broadly tracked its earnings path rather than being re-rated in either direction.
Reading the price against its own ranges
Over the last twelve months the price has covered ₹956 to ₹1,544. The current level is 68% of the way through that band, 12.11% below the 52-week high and 41.95% above the 52-week low. A mid-range price means neither the bulls nor the bears own the trend yet; the twelve-month extremes are the levels that decide which way the range resolves.
Traded quantity of 3,63,086 shares is 1.40x the 20-day average of 2,58,970. Turnover close to the recent norm suggests an orderly session rather than a scramble, so the move reflects ordinary two-way flow.
Where this goes from here
For this in focus story specifically, watch an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two. On the chart, the ₹1,386.10 high and ₹1,336.20 low of the last session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of that low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 2,58,970 shares to be read as positioning rather than a squeeze.
Trader's view versus investor's view
For a trader, this is a low-information session: the move sits inside the stock's normal daily spread, so there is no edge in chasing it. Waiting for a close outside ₹1,336.20–₹1,386.10 is the cheaper way to be positioned.
For a long-term shareholder, one session tells you very little. The stock is 12.11% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.
On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.
Our read
Global Health is being sold on an in-focus story, and at ₹1,357.00 the decline is happening on ordinary turnover, which is more often a shakeout than distribution. The day's ₹1,336.20–₹1,386.10 band is the frame for the next session, and an exchange filing from the company itself is what resolves the story either way.
Where to track MEDANTA next
Live price, charts and technicals stay on the Global Health stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.
Frequently asked questions
What is the Global Health share price in Friday's session?
Global Health (MEDANTA) last traded at ₹1,357.00, -8.00 (-0.59%) against the previous close of ₹1,365.00, read from the NSE board at the close of the last trading session on Friday, 2 October 2026.
Why is Global Health in the news in Friday's session?
1 business publisher ran headlines on the company in the last session — a in focus story. Their reports are linked above; the levels and tables here are read independently from exchange data.
What is the 52-week high and low of MEDANTA?
Over the last twelve months MEDANTA has traded between a low of ₹956 and a high of ₹1,544, computed from the adjusted daily series.
Is MEDANTA up or down in Friday's session?
MEDANTA slipped -0.59% in the last session, trading between ₹1,336.20 and ₹1,386.10 against an open of ₹1,356.90.
Is the market open right now?
No. Indian equity markets are shut on Saturday, so every level below is from the last trading session on Friday, 2 October 2026 and will not change until the next session opens.
Key takeaways
- Last price: ₹1,357.00 (-0.59%) — lower at the time of writing
- Day range: ₹1,336.20 – ₹1,386.10
- 52-week high: ₹1,544
About this report
Every figure on this page is read from a primary source at the timestamp shown — exchange boards for equities and indices, the exchange bid book for IPOs, published association rates for bullion, and consolidated exchange quotes for crypto — with no estimation or third-party commentary. Historical fields such as trailing returns and 52-week extremes are computed on the adjusted daily series so splits and bonuses do not create false gaps. A timestamp outside market hours reflects the last traded or last published value, not a live tick.
Related live pages
Sources
- NSE live board data via our exchange data feed
- Headline attribution links above point to the original publishers
- TrendRipperX Global Health stock page
“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”
Frequently asked questions
What has changed for MEDANTA?
Global Health (MEDANTA) last traded at ₹1,357.00, -8.00 (-0.59%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
How significant is global Health: what is happening in Friday's session?
Global Health (MEDANTA) last traded at ₹1,357.00, -8.00 (-0.59%) against a previous close of ₹1,365.00, read from the NSE board at the close of the last trading session on Friday, 2 October 2026.
What does key takeaways mean for investors?
Where it trades: Global Health is at ₹1,357.00, -8.00 (-0.59%) versus the previous close of ₹1,365.00. Why it is moving: an in-focus story — one business desk filed on the company in the last few hours. Today's band: ₹1,336.20 to ₹1,386.10, against an open of ₹1,356.90 — the stock is defending its opening print.
Why Global Health is on the desks in Friday's session?
Global Health is one of the most-mentioned names on the business wires right now — reported by one desk so far, with the headlines linked below.
What it means when several desks run the same name?
A publisher filed on Global Health in the last few hours without a single dominant disclosure driving it. Clustered coverage of this kind is usually attention rather than information: a screen result, a sector read-across, or a follow-up to something filed earlier in the week.
What should you know about coverage across the desks?
Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown. Global Health expands Delhi-NCR footprint with upcoming Medanta hospital in Ghaziabad- details inside — Livemint.
Comments
Comments are moderated. Be civil, no stock tips or promotions.
Loading comments…
Related articles
HINDALCO Traded Flat at ₹941.85: Inside the Regulatory Story Moving Hindalco Industries Shares
Hindalco Industries (HINDALCO) last traded at ₹941.85, +0.05 (+0.01%) as the regulatory story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
Gp Petroleums Opened Gap-Up at ₹61.40 After Fundraise Update — Levels, Volumes and the Follow-Up to Track
Gp Petroleums (GULFPETRO) last traded at ₹62.00, +1.28 (+2.11%) as the fundraise story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
RELIANCE in Focus: Reliance Industries Share Price Slipped to 52-Week Low on Rising Newsflow
Reliance Industries (RELIANCE) last traded at ₹1,167.70, -19.30 (-1.63%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Newsletter

